Criteria | Outcome measure | ||
---|---|---|---|
Necrosis Y/N | Depth (SKIN) | Total necrosis area | |
Subjectivity of measurement (κ for the first and second clinical assessment)* | |||
Sample size required to demonstrate statistically significant difference between treatment and control arm (based on observed data)† | |||
Proportion of patients with observed response** |